title: Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
abstract: The specificity of 26 monoclonal antibodies against the CA 125 antigen was investigated in two phases of the ISOBM TD-1 workshop. The binding specificity was studied using CA 125 immunoextracted by specific antibodies immobilized on various solid phases, or on the surface of human cell lines. Immunometric assays using all possible antibody combinations were used to study the topography of antibody binding sites on the antigen. We conclude that the CA 125 antigen carries only two major antigenic domains, which classifies the antibodies as OC125-like (group A) or M11-like (group B). One antibody, OV 197, showed binding specificity related to some of the OC125-like antibodies, but was classified into a separate group C. The OC125-like group of antibodies has four subgroups with different binding specificities. These are A1 = OC 125 and K 95, A2 = K 93, A3 = B43.13, and A4 = ZS 33, B27.1 and CCD 247. Binding of nonlabelled OC 125 or K 95 to CA 125 caused a marked increase in binding of labelled OV 197 to the complex. This conformational change was not observed with any other antibody combinations. Antibody B43.13 could form immunometric assay combinations particularly with antibodies of subgroup A4, indicating that the B43.13 epitope is in the periphery of the binding area of OC125-like antibodies. The M11-like group of antibodies is more homogenous with strong cross-inhibition between most antibodies. Only one antibody, ZR 38, would form an immunoassay combination with other M11-like antibodies and thus represents a distinct subgroup. The main group of M11-like antibodies are M 11, ZR 45, MA602-6, K 91, OV 185, K 101, K 90, K 96, K 97, K 102, CCD 242, 145-9, and 130-22. Antibody OV 197 binds to a domain designated C and is unique, as stated above. Antibody pairs from any two of the three groups may be used in immunometric assays. Three antibodies were not studied by complete cross-inhibition due to low affinity (OV 198 and K 100) or lack of material (MA602-1). OV 198 and K 100 are most likely OC125-like and MA602-1 is M11-like. Antibody affinity was estimated with labelled antigen in solution or with antigen absorbed on microtiter wells. Western blot analysis showed staining both in the stacking gel and corresponding to a molecule of 200 kDa. There was a marked difference between the antibodies in their ability to bind to CA 125 immobilized on a membrane. Strongest binding was observed with the M11-like antibodies, particularly M 11, K 96, K 97, MA602-6, 145-9. Antibodies belonging to the subgroup A4 were the only OC 125-like antibodies which reacted well with CA 125 in Western analysis. Digestion of CA 125 with proteolytic enzymes showed it to be particularly sensitive to trypsin cleavage. However, no low molecular weight fragments with preserved immunoreactivity were found.
authors.affiliation: Central Laboratory, Norwegian Radium Hospital, Oslo, Norway.
authors.forename: K
authors.initials: K
authors.lastname: Nustad
authors.forename: R C
authors.initials: RC
authors.lastname: Bast
authors.forename: T J
authors.initials: TJ
authors.lastname: Brien
authors.forename: O
authors.initials: O
authors.lastname: Nilsson
authors.forename: P
authors.initials: P
authors.lastname: Seguin
authors.forename: M R
authors.initials: MR
authors.lastname: Suresh
authors.forename: T
authors.initials: T
authors.lastname: Saga
authors.forename: S
authors.initials: S
authors.lastname: Nozawa
authors.forename: O P
authors.initials: OP
authors.lastname: Børmer
authors.forename: H W
authors.initials: HW
authors.lastname: de Bruijn
authors.forename: M
authors.initials: M
authors.lastname: Nap
authors.forename: A
authors.initials: A
authors.lastname: Vitali
authors.forename: M
authors.initials: M
authors.lastname: Gadnell
authors.forename: J
authors.initials: J
authors.lastname: Clark
authors.forename: K
authors.initials: K
authors.lastname: Shigemasa
authors.forename: B
authors.initials: B
authors.lastname: Karlsson
authors.forename: F T
authors.initials: FT
authors.lastname: Kreutz
authors.forename: D
authors.initials: D
authors.lastname: Jette
authors.forename: H
authors.initials: H
authors.lastname: Sakahara
authors.forename: K
authors.initials: K
authors.lastname: Endo
authors.forename: E
authors.initials: E
authors.lastname: Paus
authors.forename: D
authors.initials: D
authors.lastname: Warren
authors.forename: S
authors.initials: S
authors.lastname: Hammarström
authors.forename: P
authors.initials: P
authors.lastname: Kenemans
authors.forename: J
authors.initials: J
authors.lastname: Hilgers
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000145:classification* / Q000378:metabolism; D000915:Antibody Affinity; D000918:Antibody Specificity; D001666:Binding Sites, Antibody; D001667:Binding, Competitive; D015153:Blotting, Western; D018394:CA-125 Antigen / Q000032:analysis / Q000276:immunology*; D002478:Cells, Cultured; D003429:Cross Reactions / Q000276:immunology; D004591:Electrophoresis, Polyacrylamide Gel; D010450:Endopeptidases / Q000378:metabolism; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D051379:Mice; D051381:Rats; D012955:Societies, Medical
chemical_list: D000911:Antibodies, Monoclonal; D018394:CA-125 Antigen; D000939:Epitopes; D010450:Endopeptidases